CORRINNA O'BANNON: Open Payments
NPI 1508045808 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 88 payments from 12 companies in 2025. Trend: 2023 $283 · 2024 $319 · 2025 $1,627
Food & beverage: $1,627
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $265 |
| Novartis Pharmaceuticals Corporation | 11 | $253 |
| Boston Scientific Corporation | 9 | $243 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 20 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $180 |
| Philips North America LLC | 5 | $166 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| E.R. Squibb & Sons, L.L.C. | 5 | $79 |
| Novo Nordisk Inc | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
Products named: REPATHA, LEQVIO, LifeVest, WATCHMAN FLX, JARDIANCE, Ambulatory Monitoring & Diagnostics Undivided, ONPATTRO, CDS - MCT/CEM Monitoring.
Industry payments across SC — which companies pay providers there.
